Lexicon Pharmaceuticals
Price & Volume
Stats
See more52W Range | $0.28-$2.17 |
Market Cap | $450.6M |
Shares Short | 27M |
Financials
See moreRevenue (12 Mos) | $58.4M |
Revenue Growth (YoY) | 1,652.6% |
Gross Profit (12 Mos) | -$25.3M |
Diluted EPS | -$0.32 |
News
See moreYahoo Finance • 13 days ago
Lexicon Pharmaceuticals Inc (NASDAQ:LXRX) Q2 2025 Earnings: Revenue Soars 482% Above Estimates, Stock Gains 9.5%
Yahoo Finance • 13 days ago
Lexicon Pharmaceuticals GAAP EPS of $0.01 beats by $0.09, revenue of $28.87M
Yahoo Finance • 13 days ago
Lexicon Pharmaceuticals Reports Second Quarter 2025 Financial Results and Provides Business Updates
Yahoo Finance • 27 days ago
Lexicon Pharmaceuticals to Report Second Quarter 2025 Financial Results on August 6, 2025
About
CEO | Dr. Michael S. Exton Ph.D. |
CFO | Mr. Scott M. Coiante |
Address | 2445 Technology Forest Boulevard, The Woodlands, TX, United States, 77381 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 103 |
